Labeler
Cipla USA Inc. NDC Codes
Cipla USA Inc. lists 269 finished drug products in the FDA NDC Directory under NDC labeler code 69097.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Lanreotide Acetate, Diltiazem Hydrochloride, Lenalidomide, Lurasidone Hydrochloride, Pomalidomide, Phytonadione, Pravastatin Sodium, Fluticasone propionate and Salmeterol, Nilotinib, Potassium Phosphates, Vilazodone Hydrochloride, Pirfenidone, Deferasirox, Lanthanum carbonate, Dapagliflozin
- Active ingredients
- Lanreotide acetate, Diltiazem hydrochloride, Lenalidomide, Lurasidone hydrochloride, Pomalidomide, Phytonadione, Pravastatin sodium, Fluticasone propionate, Salmeterol xinafoate, Nilotinib, Monobasic potassium phosphate, Dibasic potassium phosphate
- NDC labeler codes
- 69097
- Strengths (from the 100 most recently listed products)
- Salmeterol xinafoate 50 ug/1; Monobasic potassium phosphate 224 mg/mL; Dibasic potassium phosphate 236 mg/mL; Liraglutide 6 mg/mL; Lanreotide acetate 120 mg/.5mL; Lanreotide acetate 60 mg/.2mL; Lanreotide acetate 90 mg/.3mL; Phytonadione 1 mg/.5mL; Pirfenidone 267 mg/1; Cyclosporine .5 mg/mL; Pomalidomide 1 mg/1; Pomalidomide 2 mg/1; Pomalidomide 3 mg/1; Pomalidomide 4 mg/1; Fluticasone propionate 250 ug/1; Fluticasone propionate 100 ug/1; Fluticasone propionate 500 ug/1; Albuterol sulfate 90 ug/1; Dapagliflozin propanediol 5 mg/1; Dapagliflozin propanediol 10 mg/1
- Dosage forms
- Capsule, Tablet, Film coated, Injection, Tablet, Tablet, Extended release, Powder, Injection, Solution, Injection, Emulsion, For suspension, Granule, Tablet, Chewable, Emulsion, Kit, Suspension, Tablet, Film coated, Extended release, Tablet, Coated, Aerosol, Metered, Injection, Powder, Lyophilized, For suspension, Gel, Granule, For solution, Solution
- Routes
- Oral, Subcutaneous, Intravenous, Intramuscular, Respiratory (Inhalation), Ophthalmic, Topical
- Drug classes (FDA established)
- Thalidomide Analog, Somatostatin Analog, Osmotic Laxative, Potassium Salt, Calcium Channel Blocker, beta2-Adrenergic Agonist, Kinase Inhibitor, Atypical Antipsychotic, Corticosteroid, Vitamin K, Warfarin Reversal Agent, HMG-CoA Reductase Inhibitor, Proton Pump Inhibitor, Protease Inhibitor, Pyridone, Iron Chelator, Phosphate Binder, Sodium-Glucose Cotransporter 2 Inhibitor, GLP-1 Receptor Agonist, Leukocyte Growth Factor, P2Y12 Platelet Inhibitor, Serotonin Reuptake Inhibitor, Serotonin-4 Receptor Agonist, Dihydropyridine Calcium Channel Blocker, Aminoketone, Androgen, Nucleoside Metabolic Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Calcineurin Inhibitor Immunosuppressant, Microtubule Inhibitor, Penicillin-class Antibacterial, beta Lactamase Inhibitor, Calcitonin, Nonsteroidal Anti-inflammatory Drug, Muscle Relaxant, Neuraminidase Inhibitor, Cytochrome P450 3A Inhibitor, Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 136 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Darunavir 600 and 800 mgdarunavir | Darunavir hydrate 600 mg/1 | TabletOral | 69097-248 | 69097-0248-03 | — |
| Bupropion Hydrochloride | Bupropion hydrochloride 150 mg/1 | Tablet, Film coated, Extended releaseOral | 69097-071 | 69097-0071-12 | — |
| Bupropion Hydrochloride | Bupropion hydrochloride 300 mg/1 | Tablet, Film coated, Extended releaseOral | 69097-072 | 69097-0072-12 | — |
| Testosterone Cypionate | Testosterone cypionate 100 mg/mL | InjectionIntramuscular | 69097-536 | 69097-0536-37 | — |
| Testosterone Cypionate | Testosterone cypionate 200 mg/mL | InjectionIntramuscular | 69097-537 | 69097-0537-3169097-0537-37 | — |
| Capecitabine | Capecitabine 500 mg/1 | Tablet, Film coatedOral | 69097-948 | 69097-0948-08 | — |
| Capecitabine | Capecitabine 150 mg/1 | Tablet, Film coatedOral | 69097-949 | 69097-0949-03 | — |
| Diltiazem Hydrochloride | Diltiazem hydrochloride 120 mg/1 | Tablet, Extended releaseOral | 69097-992 | 69097-0992-0269097-0992-05 | — |
| Diltiazem Hydrochloride | Diltiazem hydrochloride 180 mg/1 | Tablet, Extended releaseOral | 69097-993 | 69097-0993-0269097-0993-05 | — |
| Diltiazem Hydrochloride | Diltiazem hydrochloride 240 mg/1 | Tablet, Extended releaseOral | 69097-994 | 69097-0994-0269097-0994-05 | — |
| Diltiazem Hydrochloride | Diltiazem hydrochloride 300 mg/1 | Tablet, Extended releaseOral | 69097-995 | 69097-0995-0269097-0995-05 | — |
| Diltiazem Hydrochloride | Diltiazem hydrochloride 360 mg/1 | Tablet, Extended releaseOral | 69097-996 | 69097-0996-0269097-0996-05 | — |
| Diltiazem Hydrochloride | Diltiazem hydrochloride 420 mg/1 | Tablet, Extended releaseOral | 69097-997 | 69097-0997-0269097-0997-05 | — |
| Metaxalone | Metaxalone 400 mg/1 | TabletOral | 69097-998 | 69097-0998-07 | — |
| Lenalidomide | Lenalidomide 2.5 mg/1 | CapsuleOral | 69097-604 | 69097-0604-73 | — |
| lenalidomide | Lenalidomide 20 mg/1 | CapsuleOral | 69097-384 | 69097-0384-81 | — |
| Lurasidone Hydrochloride | Lurasidone hydrochloride 120 mg/1 | Tablet, Film coatedOral | 69097-937 | 69097-0937-02 | — |
| Lurasidone Hydrochloride | Lurasidone hydrochloride 80 mg/1 | Tablet, Film coatedOral | 69097-938 | 69097-0938-02 | — |
| Lurasidone Hydrochloride | Lurasidone hydrochloride 60 mg/1 | Tablet, Film coatedOral | 69097-939 | 69097-0939-02 | — |
| Lurasidone Hydrochloride | Lurasidone hydrochloride 40 mg/1 | Tablet, Film coatedOral | 69097-941 | 69097-0941-02 | — |
| Lurasidone Hydrochloride | Lurasidone hydrochloride 20 mg/1 | Tablet, Film coatedOral | 69097-942 | 69097-0942-02 | — |
| Vilazodone Hydrochloride | Vilazodone hydrochloride 10 mg/1 | Tablet, Film coatedOral | 69097-979 | 69097-0979-02 | — |
| Vilazodone hydrochloride | Vilazodone hydrochloride 20 mg/1 | Tablet, Film coatedOral | 69097-981 | 69097-0981-02 | — |
| Vilazodone hydrochloride | Vilazodone hydrochloride 40 mg/1 | Tablet, Film coatedOral | 69097-982 | 69097-0982-02 | — |
| Oseltamivir Phosphate | Oseltamivir phosphate 6 mg/mL | For suspensionOral | 69097-904 | 69097-0904-43 | — |
| lenalidomide | Lenalidomide 5 mg/1 | CapsuleOral | 69097-381 | 69097-0381-73 | — |
| lenalidomide | Lenalidomide 10 mg/1 | CapsuleOral | 69097-382 | 69097-0382-73 | — |
| lenalidomide | Lenalidomide 15 mg/1 | CapsuleOral | 69097-383 | 69097-0383-81 | — |
| lenalidomide | Lenalidomide 25 mg/1 | CapsuleOral | 69097-385 | 69097-0385-81 | — |
| Pirfenidone | Pirfenidone 267 mg/1 | Tablet, CoatedOral | 69097-987 | 69097-0987-0569097-0987-93 | — |
| Pirfenidone | Pirfenidone 801 mg/1 | Tablet, CoatedOral | 69097-988 | 69097-0988-0569097-0988-93 | — |
| Pirfenidone | Pirfenidone 267 mg/1 | CapsuleOral | 69097-940 | 69097-0940-0469097-0940-93 | — |
| Leuprolide Acetate Depotleuprolide acetate | — | Kit | 69097-909 | 69097-0909-50 | — |
| Phytonadione | Phytonadione 10 mg/mL | Injection, EmulsionIntramuscular, Intravenous, Subcutaneous | 69097-708 | 69097-0708-96 | — |
| Phytonadione | Phytonadione 1 mg/.5mL | Injection, EmulsionIntramuscular, Intravenous, Subcutaneous | 69097-709 | 69097-0709-96 | — |
| Ritonavir film coatedritonavir 100 mg | Ritonavir 100 mg/1 | TabletOral | 69097-655 | 69097-0655-0269097-0655-08 | — |
| Deferasirox | Deferasirox 90 mg/1 | GranuleOral | 69097-550 | 69097-0550-53 | — |
| Deferasirox | Deferasirox 180 mg/1 | GranuleOral | 69097-560 | 69097-0560-53 | — |
| Deferasirox | Deferasirox 360 mg/1 | GranuleOral | 69097-570 | 69097-0570-53 | — |
| Fosfomycin Tromethamine | Fosfomycin tromethamine 3 g/1 | Granule, For solutionOral | 69097-579 | 69097-0579-67 | — |
| Lanthanum carbonate | Lanthanum carbonate 500 mg/1 | Tablet, ChewableOral | 69097-934 | 69097-0934-98 | — |
| Lanthanum carbonate | Lanthanum carbonate 750 mg/1 | Tablet, ChewableOral | 69097-935 | 69097-0935-98 | — |
| Lanthanum carbonate | Lanthanum carbonate 1000 mg/1 | Tablet, ChewableOral | 69097-936 | 69097-0936-98 | — |
| Lanreotide Acetate | Lanreotide acetate 120 mg/.5mL | InjectionSubcutaneous | 69097-870 | 69097-0870-67 | — |
| Lanreotide Acetate | Lanreotide acetate 60 mg/.2mL | InjectionSubcutaneous | 69097-880 | 69097-0880-67 | — |
| Lanreotide Acetate | Lanreotide acetate 90 mg/.3mL | InjectionSubcutaneous | 69097-890 | 69097-0890-67 | — |
| Emtricitabine And Tenofovir Disoproxil Fumarate | Emtricitabine 200 mg/1; Tenofovir disoproxil fumarate 300 mg/1 | Tablet, Film coatedOral | 69097-741 | 69097-0741-02 | — |
| Difluprednate | Difluprednate .5 mg/mL | EmulsionOphthalmic | 69097-341 | 69097-0341-35 | — |
| arformoterol tartrate | Arformoterol tartrate 15 ug/2mL | SolutionRespiratory (Inhalation) | 69097-168 | 69097-0168-5369097-0168-6469097-0168-87 | — |
| Meprobamate | Meprobamate 200 mg/1 | TabletOral | 69097-974 | 69097-0974-07 | — |
Cipla USA Inc.: common questions
- What is Cipla USA Inc.'s NDC labeler code?
- 69097. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Cipla USA Inc.?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.